Hematology NewsMinimal residual disease measures not yet impactful for AML patientsOctober 12, 2017AMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesPredicting neurotoxicity after CAR T-cell therapyOctober 12, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA grants drug fast track designation for rel/ref AMLOctober 12, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesAntithrombotic agents linked to hematuria-related complicationsOctober 12, 2017Thrombosis
Oncology PracticeHyperlipidemia diagnosis protects against breast cancerOctober 11, 2017Breast Cancer
Hematology TimesImmunotherapy demonstrates potential for T-cell lymphomaOctober 11, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesAML trial placed on full clinical holdOctober 11, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesFDA rejects pegfilgrastim biosimilarOctober 11, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Oncology PracticeCDC: Forty percent of cancers linked to overweight or obesityOctober 10, 2017Preventive Care
Hematology TimesTeam identifies genetic drivers of DLBCLOctober 10, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA grants drug orphan designation for AMLOctober 10, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsALL therapies grow, so do the complexities of choosing the order of treatmentsOctober 9, 2017ALLLeukemia, Myelodysplasia, Transplantation
